Overview of Safety Committees

Session eight of the Navigating Research Protections Series provides an overview of HMRI Safety Committees’ purpose, scope, and essential role in maintaining research compliance and safety. The focus of this session is the Institutional Biosafety Committee (IBC), which reviews research involving recombinant and or synthetic nucleic acids molecules. Safety Committee experts will walk through the regulations and institutional policies governing research subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules and common challenges researchers encounter when completing IBC-related documentation.

This program is offered by the Office of Faculty & Research Development in collaboration with Office of Research Protections